ArticleGut2003

A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.

B M Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.